Amendments to Singapore’s Health Products (Therapeutic Products) Regulations (the TPR) came into force on August 1, 2024, relating to patent linkage. By way of background, the patent linkage regime in Singapore under the TPR before the amendments came into effect on August 1, 2024, requires an applicant for product registration and marketing approval of a […]
Tag: patent linkage
A second-round victory for brand drug owners against generics who fail to declare relevant patents under Singapore’s patent linkage regime
Proprietors of brand-name drugs may heave another sigh of relief as the Singapore Court of Appeal in Zyfas Medical Co (Sued as a firm) v. Millennium Pharmaceuticals, Inc [2020] SGCA 84 re-affirmed its holding in Millennium Pharmaceuticals, Inc v. Drug Houses of Australia Pte Ltd [2019] SGCA 31 (the DHA decision) rejecting an overly-restrictive interpretation […]